|
|
Volumn 8, Issue 3, 2008, Pages 228-236
|
|
Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
APOLIPOPROTEIN A5;
APOLIPOPROTEIN C3;
CLOZAPINE;
LIPOPROTEIN LIPASE;
NEUROLEPTIC AGENT;
OLANZAPINE;
RISPERIDONE;
ADULT;
ARTICLE;
CHOLESTEROL BLOOD LEVEL;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
CROSS-SECTIONAL STUDY;
DRUG EFFICACY;
DRUG RESPONSE;
EXPLORATORY RESEARCH;
FEMALE;
GENETIC ANALYSIS;
GENETIC VARIABILITY;
HAPLOTYPE;
HUMAN;
LIPID BLOOD LEVEL;
LIPID METABOLISM;
MAJOR CLINICAL STUDY;
MALE;
MONOTHERAPY;
PHARMACOGENETICS;
PRIORITY JOURNAL;
SCHIZOAFFECTIVE PSYCHOSIS;
SCHIZOPHRENIA;
SINGLE NUCLEOTIDE POLYMORPHISM;
TRIACYLGLYCEROL BLOOD LEVEL;
ADULT;
ALLELES;
ANTIPSYCHOTIC AGENTS;
APOLIPOPROTEIN C-III;
APOLIPOPROTEINS A;
BENZODIAZEPINES;
CLOZAPINE;
CROSS-SECTIONAL STUDIES;
FEMALE;
HAPLOTYPES;
HUMANS;
LIPIDS;
LIPOPROTEIN LIPASE;
MALE;
MIDDLE AGED;
POLYMORPHISM, SINGLE NUCLEOTIDE;
SCHIZOPHRENIA;
|
|
EID: 44049109281
PISSN: 1470269X
EISSN: 14731150
Source Type: Journal
DOI: 10.1038/sj.tpj.6500474 Document Type: Article |
|
Times cited : (34)
|
|
References (35)
|
